4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-035447
President and CEO sold 21,120 shares at an average $55.21 ($1,166,105)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENDHEIM JACK · President and CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-24 | Sale : show line 1 in the form 10b5-1 | −6,523 | $52.88 | $344,918 | 66,797 | I |
| 2026-03-24 | Sale : show line 2 in the form 10b5-1 | −517 | $53.59 | $27,705 | 66,280 | I |
| 2026-03-25 | Sale : show line 3 in the form 10b5-1 | −1,572 | $55.28 | $86,904 | 64,708 | I |
| 2026-03-25 | Sale : show line 4 in the form 10b5-1 | −4,916 | $56.00 | $275,316 | 59,792 | I |
| 2026-03-25 | Sale : show line 5 in the form 10b5-1 | −552 | $56.86 | $31,386 | 59,240 | I |
| 2026-03-26 | Sale : show line 6 in the form 10b5-1 | −6,760 | $56.79 | $383,868 | 52,480 | I |
| 2026-03-26 | Sale : show line 7 in the form 10b5-1 | −280 | $57.17 | $16,008 | 52,200 | I |
| Open-market sales · 21,120 sh · avg $55.21 · $1,166,105 | ||||||
Loading xslF345X06/tm269871-1_4seq1.xml…